EP-1091: IMRT/IGRT of 76Gy for intermediate and high risk prostate cancer combined with neoadjuvant and concurrent ADT
2013
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI